Hem › Metastaserande cancer › Kalifornien › Mountain View
Kliniska studier för Metastaserande cancer i Mountain View, CA
25 studier för Metastaserande cancer söker deltagare vid platser i och runt Mountain View (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi bort
- VA Palo Alto Health Care System, Palo Alto · 5 mi bort
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RekryterarFas 1/2
- Stanford, Palo Alto · 5 mi bort
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekryterarFas 2/3
- Stanford Cancer Center, Palo Alto · 5 mi bort
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekryterarFas 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mi bort
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RekryterarFas 1/2
- Stanford Medicine, Palo Alto · 5 mi bort
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RekryterarFas 1
- Stanford Cancer Institute, Stanford · 5 mi bort
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekryterarFas 1
- Stanford University Medical Center, Stanford · 5 mi bort
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekryterarFas 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi bort
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekryterarFas 3
- Stanford Cancer Center, Palo Alto · 5 mi bort
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekryterarFas 1/2
- Stanford Cancer Institute, Stanford · 5 mi bort
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
RekryterarFas 2
- Stanford University, Palo Alto · 5 mi bort
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekryterarFas 3
- Research Site, Palo Alto · 5 mi bort
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
RekryterarFas 1/2
- Stanford Cancer Institute (SCI), Stanford · 5 mi bort
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekryterarFas 1
- Stanford Medicine Cancer Center, Stanford · 5 mi bort
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi bort
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RekryterarFas 3
- Stanford University School of Medicine, Palo Alto · 5 mi bort
A Study of LY4175408 in Participants With Advanced Cancer
RekryterarFas 1
- Stanford Medicine Cancer Center, Stanford · 5 mi bort
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekryterarFas 1/2
- Stanford Cancer Institute, Stanford · 5 mi bort
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RekryterarFas 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · 5 mi bort
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekryterarFas 2/3
- Stanford Cancer Institute, Palo Alto · 5 mi bort
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RekryterarFas 1
- Stanford Cancer Institute, Stanford · 5 mi bort
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
RekryterarFas 1
- Stanford Cancer Institute, Stanford · 5 mi bort
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
RekryterarObservationsstudie
- VA Palo Alto Healthcare System, Palo Alto · 5 mi bort
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RekryterarFas 1
- Stanford Cancer Institute, Palo Alto · 5 mi bort
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi bort
Metastaserande cancer-studier i andra städer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andra studier i Mountain View
- Cancer (alla typer)40 studier
- Bröstcancer26 studier
- Icke-småcellig lungcancer21 studier
- Akut myeloid leukemi19 studier
- Äggstockscancer19 studier
- Autismspektrumstörning17 studier
- Lungcancer17 studier
- Prostatacancer15 studier
- Hjärtsvikt15 studier
- Autism13 studier
- Akut lymfoblastisk leukemi13 studier
- Kolorektal cancer13 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.